NO20011633L - Nye krystallmodifikasjoner av torasemid - Google Patents

Nye krystallmodifikasjoner av torasemid

Info

Publication number: NO20011633L
Authority: NO; Norway
Prior art keywords: torasemide; new; preparation; form iii; alkaline
Prior art date: 1998-10-02

Application number

NO20011633A

Other languages

English (en)

Other versions

NO317107B1 (no

NO20011633D0 (no

Inventor

Darko Filic

Miljenko Dumic

Aleksandar Danilovski

Bozena Klepic

Ines Fistric

Marina Oresic

Mikulcic Jasna Horvat

Original Assignee

Pliva Pharm & Chem Works

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-02

Filing date

2001-03-30

Publication date

2001-03-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10946825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20011633(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-03-30 Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works

2001-03-30 Publication of NO20011633D0 publication Critical patent/NO20011633D0/no

2001-03-30 Publication of NO20011633L publication Critical patent/NO20011633L/no

2004-08-09 Publication of NO317107B1 publication Critical patent/NO317107B1/no

Links

NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 title abstract 5
229960005461 torasemide Drugs 0.000 title abstract 5
239000013078 crystal Substances 0.000 title abstract 3
230000004048 modification Effects 0.000 title abstract 3
238000012986 modification Methods 0.000 title abstract 3
230000020477 pH reduction Effects 0.000 abstract 2
208000001953 Hypotension Diseases 0.000 abstract 1
230000003266 anti-allergic effect Effects 0.000 abstract 1
230000001088 anti-asthma Effects 0.000 abstract 1
230000001773 anti-convulsant effect Effects 0.000 abstract 1
239000000924 antiasthmatic agent Substances 0.000 abstract 1
239000001961 anticonvulsive agent Substances 0.000 abstract 1
229960003965 antiepileptics Drugs 0.000 abstract 1
239000000824 cytostatic agent Substances 0.000 abstract 1
230000001085 cytostatic effect Effects 0.000 abstract 1
239000002934 diuretic Substances 0.000 abstract 1
230000001882 diuretic effect Effects 0.000 abstract 1
230000002526 effect on cardiovascular system Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
208000021822 hypotensive Diseases 0.000 abstract 1
230000001077 hypotensive effect Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
150000007522 mineralic acids Chemical class 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
235000005985 organic acids Nutrition 0.000 abstract 1
238000000634 powder X-ray diffraction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Liquid Crystal Substances (AREA)
Liquid Crystal (AREA)
Enzymes And Modification Thereof (AREA)
Pyridine Compounds (AREA)
Medicinal Preparation (AREA)

NO20011633A 1998-10-02 2001-03-30 Ny krystallmodifikasjon av torasemid, fremgangsmate for fremstilling derav, samt farmasoytisk preparat NO317107B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HR980532A HRP980532B1 (en)	1998-10-02	1998-10-02	Novel crystalline torasemide modification
PCT/HR1999/000023 WO2000020395A1 (en)	1998-10-02	1999-10-01	New crystal modification iii of torasemide

Publications (3)

Publication Number	Publication Date
NO20011633D0 NO20011633D0 (no)	2001-03-30
NO20011633L true NO20011633L (no)	2001-03-30
NO317107B1 NO317107B1 (no)	2004-08-09

Family

ID=10946825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011633A NO317107B1 (no)	1998-10-02	2001-03-30	Ny krystallmodifikasjon av torasemid, fremgangsmate for fremstilling derav, samt farmasoytisk preparat

Country Status (32)

Country	Link
US (5)	US6399637B1 (no)
EP (1)	EP1117643B1 (no)
JP (1)	JP2002526532A (no)
KR (1)	KR100437307B1 (no)
CN (1)	CN1125049C (no)
AT (1)	ATE286024T1 (no)
AU (1)	AU759291B2 (no)
BG (1)	BG105485A (no)
BR (1)	BR9915018A (no)
CA (1)	CA2345789A1 (no)
CZ (1)	CZ20011031A3 (no)
DE (2)	DE29924789U1 (no)
DK (1)	DK1117643T3 (no)
EE (1)	EE04341B1 (no)
ES (1)	ES2237158T3 (no)
HK (1)	HK1040250B (no)
HR (1)	HRP980532B1 (no)
HU (1)	HUP0104009A3 (no)
ID (1)	ID29931A (no)
IL (1)	IL142150A0 (no)
NO (1)	NO317107B1 (no)
NZ (1)	NZ510898A (no)
PL (1)	PL346975A1 (no)
PT (1)	PT1117643E (no)
RU (1)	RU2210569C2 (no)
SI (1)	SI1117643T1 (no)
SK (1)	SK4232001A3 (no)
TR (1)	TR200100909T2 (no)
UA (1)	UA72895C2 (no)
WO (1)	WO2000020395A1 (no)
YU (1)	YU24001A (no)
ZA (1)	ZA200102451B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6394707B1 (en)	1997-05-08	2002-05-28	Jack Kennedy Metal Products & Buildings, Inc.	Yieldable mine roof support
HRP980532B1 (en)	1998-10-02	2005-06-30	Pliva	Novel crystalline torasemide modification
JP2003527319A (ja) *	1999-08-11	2003-09-16	テバファーマシューティカルインダストリーズリミティド	トルセミド多形体
DE10013289A1 (de) *	2000-03-17	2001-09-20	Knoll Ag	Torasemid enthaltende pharmazeutische Zubereitungen
HRP20000162B1 (en)	2000-03-20	2004-06-30	Pliva D D	Amorphous torasemide modification
HRP20000328A2 (en) *	2000-05-19	2002-02-28	Pliva Farmaceutska Ind Dionik	Novel polymorph v of torasemide
IN192178B (no)	2001-08-03	2004-03-06	Ranbaxy Lab
HRP20020603B1 (en) *	2002-07-19	2008-11-30	Pliva D.D.	New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
CA2424644A1 (en) *	2003-04-07	2004-10-07	David John Mckenzie	Preparation of torasemide
US20050065183A1 (en) *	2003-07-31	2005-03-24	Indranil Nandi	Fexofenadine composition and process for preparing
CA2568640C (en)	2004-06-04	2011-08-09	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
JP4406845B2 (ja) *	2007-02-20	2010-02-03	トヨタ自動車株式会社	二次電池電極材の剥離剤及び該剥離剤を用いた二次電池の処理方法
EP2705843A1 (en) *	2012-09-05	2014-03-12	Pharnext	Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesis
CN104370805B (zh) *	2013-08-13	2016-09-07	天津汉瑞药业有限公司	托拉塞米化合物
CN106038500A (zh) *	2016-05-26	2016-10-26	南京正科医药股份有限公司	一种托拉塞米片
CN115417810B (zh) *	2022-09-22	2023-10-10	南京正科医药股份有限公司	一种托拉塞米晶型ⅰ的精制方法
CN117486789A (zh) *	2023-12-29	2024-02-02	江西中医药大学	一种托拉塞米共晶盐及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1477664A (en) *	1974-04-17	1977-06-22	Christiaens Sa A	Pyridine derivatives
US4055650A (en) *	1974-04-17	1977-10-25	A. Christiaens Societe Anonyme	Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
US4473693A (en)	1978-08-04	1984-09-25	Stewart Walter W	Aminonaphthalimide dyes for intracellular labelling
DE3529529A1 (de) *	1985-08-17	1987-02-19	Boehringer Mannheim Gmbh	Verfahren zur herstellung einer stabilen modifikation von torasemid
US6166041A (en) *	1995-10-11	2000-12-26	Euro-Celtique, S.A.	2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
HRP980532B1 (en)	1998-10-02	2005-06-30	Pliva	Novel crystalline torasemide modification
US6166045A (en) *	1998-06-02	2000-12-26	Roche Diagnostics Gmbh	Torasemide of modification III
US5914336A (en) *	1998-06-02	1999-06-22	Boehringer Mannheim Gmbh	Method of controlling the serum solubility of orally administered torasemide and composition relating thereto

1998
- 1998-10-02 HR HR980532A patent/HRP980532B1/xx not_active IP Right Cessation
1999
- 1999-10-01 EE EEP200100194A patent/EE04341B1/xx not_active IP Right Cessation
- 1999-10-01 YU YU24001A patent/YU24001A/sh unknown
- 1999-10-01 CA CA002345789A patent/CA2345789A1/en not_active Abandoned
- 1999-10-01 DE DE29924789U patent/DE29924789U1/de not_active Expired - Lifetime
- 1999-10-01 DK DK99949272T patent/DK1117643T3/da active
- 1999-10-01 KR KR10-2001-7004079A patent/KR100437307B1/ko not_active Expired - Fee Related
- 1999-10-01 CN CN99811710A patent/CN1125049C/zh not_active Expired - Fee Related
- 1999-10-01 HK HK02102011.9A patent/HK1040250B/zh not_active IP Right Cessation
- 1999-10-01 UA UA2001031966A patent/UA72895C2/uk unknown
- 1999-10-01 PL PL99346975A patent/PL346975A1/xx not_active Application Discontinuation
- 1999-10-01 AT AT99949272T patent/ATE286024T1/de not_active IP Right Cessation
- 1999-10-01 NZ NZ510898A patent/NZ510898A/xx unknown
- 1999-10-01 RU RU2001111831/04A patent/RU2210569C2/ru not_active IP Right Cessation
- 1999-10-01 HU HU0104009A patent/HUP0104009A3/hu unknown
- 1999-10-01 ZA ZA200102451A patent/ZA200102451B/en unknown
- 1999-10-01 JP JP2000574512A patent/JP2002526532A/ja active Pending
- 1999-10-01 CZ CZ20011031A patent/CZ20011031A3/cs unknown
- 1999-10-01 ID IDW20010958A patent/ID29931A/id unknown
- 1999-10-01 IL IL14215099A patent/IL142150A0/xx unknown
- 1999-10-01 AU AU62240/99A patent/AU759291B2/en not_active Ceased
- 1999-10-01 TR TR2001/00909T patent/TR200100909T2/xx unknown
- 1999-10-01 PT PT99949272T patent/PT1117643E/pt unknown
- 1999-10-01 BR BR9915018-2A patent/BR9915018A/pt not_active IP Right Cessation
- 1999-10-01 SI SI9930744T patent/SI1117643T1/xx unknown
- 1999-10-01 DE DE69922977T patent/DE69922977C5/de not_active Revoked
- 1999-10-01 ES ES99949272T patent/ES2237158T3/es not_active Expired - Lifetime
- 1999-10-01 WO PCT/HR1999/000023 patent/WO2000020395A1/en not_active Ceased
- 1999-10-01 EP EP99949272A patent/EP1117643B1/en not_active Revoked
- 1999-10-01 SK SK423-2001A patent/SK4232001A3/sk not_active Application Discontinuation
- 1999-11-05 US US09/434,439 patent/US6399637B1/en not_active Expired - Fee Related
2001
- 2001-03-30 NO NO20011633A patent/NO317107B1/no unknown
- 2001-05-02 BG BG105485A patent/BG105485A/xx unknown
2002
- 2002-03-13 US US10/096,277 patent/US6833379B2/en not_active Expired - Fee Related
2004
- 2004-06-21 US US10/871,667 patent/US20040229919A1/en not_active Abandoned
2006
- 2006-02-21 US US11/357,109 patent/US20060205951A1/en not_active Abandoned
2007
- 2007-07-03 US US11/822,274 patent/US20070276015A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EE04341B1 (et)	2004-08-16
ES2237158T3 (es)	2005-07-16
BG105485A (en)	2002-01-31
AU759291B2 (en)	2003-04-10
CZ20011031A3 (cs)	2001-08-15
US6833379B2 (en)	2004-12-21
PT1117643E (pt)	2005-05-31
CN1125049C (zh)	2003-10-22
US20020147346A1 (en)	2002-10-10
CA2345789A1 (en)	2000-04-13
ZA200102451B (en)	2001-09-28
BR9915018A (pt)	2001-08-14
HUP0104009A2 (hu)	2002-02-28
YU24001A (sh)	2003-02-28
DE29924789U1 (de)	2005-08-25
JP2002526532A (ja)	2002-08-20
HUP0104009A3 (en)	2002-04-29
SI1117643T1 (en)	2005-06-30
RU2210569C2 (ru)	2003-08-20
EE200100194A (et)	2002-06-17
UA72895C2 (uk)	2005-05-16
DK1117643T3 (da)	2005-03-29
HRP980532A2 (en)	2000-12-31
EP1117643A1 (en)	2001-07-25
US20060205951A1 (en)	2006-09-14
AU6224099A (en)	2000-04-26
PL346975A1 (en)	2002-03-11
ATE286024T1 (de)	2005-01-15
HK1040250A1 (en)	2002-05-31
WO2000020395A1 (en)	2000-04-13
IL142150A0 (en)	2002-03-10
NO317107B1 (no)	2004-08-09
US20030055258A2 (en)	2003-03-20
EP1117643B1 (en)	2004-12-29
DE69922977T2 (de)	2005-12-08
SK4232001A3 (en)	2001-10-08
HK1040250B (zh)	2004-03-05
NO20011633D0 (no)	2001-03-30
ID29931A (id)	2001-10-25
HRP980532B1 (en)	2005-06-30
NZ510898A (en)	2002-10-25
KR20010079962A (ko)	2001-08-22
TR200100909T2 (tr)	2001-07-23
US20070276015A1 (en)	2007-11-29
CN1321149A (zh)	2001-11-07
DE69922977C5 (de)	2008-12-24
US6399637B1 (en)	2002-06-04
KR100437307B1 (ko)	2004-06-25
US20040229919A1 (en)	2004-11-18
DE69922977D1 (de)	2005-02-03

Publication	Publication Date	Title
NO20011633D0 (no)	2001-03-30	Nye krystallmodifikasjoner av torasemid
HRPK20000092B1 (hr)	2001-10-31	Polimorfne modifikacije 2-(3-cijano-4-izobutiloksifenil)-4-metil-5-tiazol-karboksilne kiseline i postupak njihova dobivanja
DE69504663D1 (de)	1998-10-15	KATHODENMATERIAL FÜR Li-SEKUNDÄRBATTERIEN UND VERFAHREN UND VORLÄUFERMATERIAL ZU DEREN HERSTELLUNG
BR9909567B1 (pt)	2010-07-13	composição agricolamente ativa, processo para a preparação de um composto, processos eletroquìmicos para a preparação de um composto e de hidróxido de n,n-dimetilpiperidìnio, composto, concentrado de suspensão, e, processo para regular o crescimento de planta.
WO2003059907A1 (en)	2003-07-24	Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
RU2001111831A (ru)	2003-05-20	Кристаллическая модификация n-тораземида, способ ее получения, фармацевтическая форма
AU7829787A (en)	1988-03-17	Naphthalene and indan derivatives
IE800208L (en)	1980-08-02	Production of isosorbide-5-nitrate
ATE51226T1 (de)	1990-04-15	Cyclohexenonderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
JPH10106566A5 (no)	2004-09-24
NZ513163A (en)	2004-02-27	Method for rapidly obtaining crystals with desirable morphologies
CA2297112A1 (en)	1999-03-04	Dicyclanil polymorphs and hydrates and their preparation
EP1195356A4 (en)	2006-06-07	SHEET METAL TITANATE COMPOSITE AND METHOD FOR THE PRODUCTION THEREOF
AU3300893A (en)	1993-09-23	Diacetyl production
IE780546L (en)	1978-09-21	1,2-methylene steroids
EP0891972A4 (en)	2000-12-13	SUBSTITUTED BENZOIC ACID DERIVATIVES 3- (ISOXAZOL-5-YL) AND PROCESS FOR PRODUCING THE SAME
Zachwieja	1993	Single Crystal Growth and Structure Refinement of NaAu sub 2--a New Synthesis Method for Alkali Metal--Gold Compounds
JPS5435197A (en)	1979-03-15	Preparation of zinc hydroxide platy crystals
CN101219981B (zh)	2011-01-19	反式-4-烷硫基肉桂酸的制备方法
JPS5639043A (en)	1981-04-14	Cyclopropanecarboxylic acid ester and insecticide and miticide
Andrade et al.	1984	A simple physiological model for flower induction involving circadian rhythms and phytochrome
AU7652794A (en)	1995-03-21	Novel phenyl glyoxylic acid derivatives, processes for producing them and their use as herbicides and plant growth regulators
EP0400558A3 (en)	1992-03-04	Phenylacetic acid derivative
Hamou et al.	1985	Study of the Kinetics of Crystallization of Amorphous Selenium. Influence of Substrate Treatments
Berry	2000	Process heating with affordable cascade control